Elisabetta Marangoni

Université Paris Sciences et Lettres — France

Medicine · Health Sciences

49h-index8.2kcitations477works1.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Advanced Breast Cancer Therapies(119), Estrogen and related hormone effects(117), Cancer Cells and Metastasis(66), Cancer Genomics and Diagnostics(59), Cancer-related Molecular Pathways(40)

Publications477 total

Matched single-cell chromatin, transcriptome, and surface marker profiling captures in vivo epigenomic reprogramming during basal-to-luminal transition in the mammary gland
2026Open Access
Matched single-cell chromatin, transcriptome, and cell surface marker profiling uncovers epigenomic priming of cell fate in the mammary gland
Zenodo (CERN European Organization for Nuclear Research)·2026Open Access
Matched single-cell chromatin, transcriptome, and cell surface marker profiling uncovers epigenomic priming of cell fate in the mammary gland
Zenodo (CERN European Organization for Nuclear Research)·2026Open Access
SCANDARE: an institutional dynamic prospective interventional biobanking study
BMC Cancer·2026Open Access
Figure FS5 from Tinengotinib (TT-00420), a Novel Spectrum-Selective Small-Molecule Kinase Inhibitor, Is Highly Active Against Triple-Negative Breast Cancer
2025Open Access
Figure FS7 from Tinengotinib (TT-00420), a Novel Spectrum-Selective Small-Molecule Kinase Inhibitor, Is Highly Active Against Triple-Negative Breast Cancer
2025Open Access
<i>ESR1</i> -Activating Mutations Confer Metabolic Vulnerabilities in ER+ Breast Cancer
Cancer Research·2025
Characterization of Drug-Tolerant Persister Cells in Triple-Negative Breast Cancer Identifies a Shared Persistence Program across Treatments and Patients
Cancer Research·2025· 2 citedOpen Access
Tumor-on-Chip as a Personalised Platform for Rapid Drug-Testing in Breast Cancer
2025Open Access
Label-free DIA-NN enabled RIME (DIANNeR) reveals glucocorticoid receptor interaction networks in breast, bladder, and blood across normal untransformed cells, cancer cell lines, and PDXs
2025· 1 citedOpen Access
Spatiotemporal dynamics of tumor microenvironment remodeling
2025· 2 citedOpen Access
Curcumin Induces Homologous Recombination Deficiency by BRCA2 Degradation in Breast Cancer and Normal Cells
Cancers·2025· 2 citedOpen Access
Abstract PS4-02: Patient-derived Xenografts (PDX) Allow Deconvolution of Combination Chemotherapy Response
Clinical Cancer Research·2025
Abstract P4-08-06: Onvansertib enhances the anti-tumor efficacy of trastuzumab deruxtecan in CDK4/6 inhibitor-resistant HR+/HER2- breast cancer patient-derived xenograft models
Clinical Cancer Research·2025· 1 cited
Abstract P2-07-26: Onvansertib shows synergistic efficacy in combination with paclitaxel in HR+ breast cancer: Mechanistic insights from preclinical models
Clinical Cancer Research·2025
Supplementary Table 6 from Acetalax and Bisacodyl for the Treatment of Triple-Negative Breast Cancer: A Combined Molecular and Preclinical Study
2025Open Access
Supplementary Figure 5 from Acetalax and Bisacodyl for the Treatment of Triple-Negative Breast Cancer: A Combined Molecular and Preclinical Study
2025Open Access
Supplementary Table 7 from Acetalax and Bisacodyl for the Treatment of Triple-Negative Breast Cancer: A Combined Molecular and Preclinical Study
2025Open Access
Supplementary Table 5 from Acetalax and Bisacodyl for the Treatment of Triple-Negative Breast Cancer: A Combined Molecular and Preclinical Study
2025Open Access
Supplementary Figure 4 from Acetalax and Bisacodyl for the Treatment of Triple-Negative Breast Cancer: A Combined Molecular and Preclinical Study
2025Open Access
page 1 of 24Next →

Frequent Co-authors

Anne Vincent‐Salomon(17), Ivan Bièche(15), Sophie Château‐Joubert(12), Élodie Montaudon(11), Sophie Vacher(11), Fariba Némati(9), Didier Decaudin(9), Rania El Botty(9), Ahmed Dahmani(8), Franck Assayag(8), David Gentien(8), Sergio Roman‐Roman(7), Laura Sourd(7), Marie‐France Poupon(6), Florence Coussy(6), Pierre Painsec(6), Jean‐Luc Servely(6), Thibaut Larcher(6), Fabien Reyal(5), Paul Cottu(5)